An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
Fungal infections are often challenging to manage, given the limited numbers of therapeutics and a general lack of applicable clinical literature for their use in a given animal species. This article reviews some of the underlying principles that can affect the therapeutic outcome for a given antifungal, and provides specific information from the literature that is intended to highlight the distinctive properties of the most commonly used antifungals in veterinary medicine to better facilitate their successful application in clinical practice.
Hector
Richard F
RF
Institute for Global Health, University of California San Francisco, San Francisco, CA 94105, USA. rhector@psg.ucsf.edu
D000666:Amphotericin B / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001230:Aspergillus / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D015725:Fluconazole / Q000494:pharmacology / Q000627:therapeutic use; D006118:Griseofulvin / Q000494:pharmacology / Q000627:therapeutic use; D017964:Itraconazole / Q000494:pharmacology / Q000627:therapeutic use; D007654:Ketoconazole / Q000494:pharmacology / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary*; D012720:Severity of Illness Index
D000935:Antifungal Agents; D017964:Itraconazole; D006118:Griseofulvin; D000666:Amphotericin B; D015725:Fluconazole; D007654:Ketoconazole